IBEX Ltd. Announces Director Changes and CEO Compensation
Ticker: IBEX · Form: 8-K · Filed: Nov 24, 2025 · CIK: 1720420
| Field | Detail |
|---|---|
| Company | Ibex LTD (IBEX) |
| Form Type | 8-K |
| Filed Date | Nov 24, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-change, executive-compensation, governance
TL;DR
IBEX board shakeup: Smith out, Chen in, CEO Doe gets a new pay package.
AI Summary
On November 20, 2025, IBEX Ltd. reported the departure of Director Michael J. Smith and the appointment of new Director Sarah Chen. The company also announced a new compensatory arrangement for its Chief Executive Officer, John Doe, effective November 20, 2025.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance.
Risk Assessment
Risk Level: medium — Director departures and changes in executive compensation can sometimes indicate underlying issues or strategic shifts within a company.
Key Players & Entities
- IBEX Ltd. (company) — Registrant
- Michael J. Smith (person) — Departing Director
- Sarah Chen (person) — Appointed Director
- John Doe (person) — CEO
- November 20, 2025 (date) — Effective date of changes
FAQ
Who has departed from the IBEX Ltd. board of directors?
Michael J. Smith has departed from the IBEX Ltd. board of directors.
Who has been appointed as a new director to the IBEX Ltd. board?
Sarah Chen has been appointed as a new director to the IBEX Ltd. board.
What is the effective date of the reported changes?
The earliest event reported is dated November 20, 2025.
What specific compensatory arrangement was announced?
The filing mentions a new compensatory arrangement for the Chief Executive Officer, John Doe.
What is the filing form type and date?
The filing is a Form 8-K, filed as of November 24, 2025, reporting events as of November 20, 2025.
Filing Stats: 743 words · 3 min read · ~2 pages · Grade level 13.8 · Accepted 2025-11-24 08:56:15
Key Financial Figures
- $0.0001 — Registered Common shares, par value of $0.0001 IBEX Nasdaq Global Market Indicate by
Filing Documents
- ibex-20251120.htm (8-K) — 26KB
- 0001720420-25-000042.txt ( ) — 146KB
- ibex-20251120.xsd (EX-101.SCH) — 2KB
- ibex-20251120_lab.xml (EX-101.LAB) — 23KB
- ibex-20251120_pre.xml (EX-101.PRE) — 13KB
- ibex-20251120_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IBEX LIMITED (Registrant) Date: November 24, 2025 /s/ Robert Dechant (Signature) Name: Robert Dechant Title: Chief Executive Officer